about
Inherited variation in immune genes and pathways and glioblastoma riskChallenges and developing solutions for increasing the benefits of IL-2 treatment in tumor therapy.Interleukin-13 receptor α2 DNA prime boost vaccine induces tumor immunity in murine tumor modelsCancer immunotherapy using virally transduced dendritic cells: animal studies and human clinical trials.DC-based cancer vaccines.Tumor-infiltrating PD1-Positive Lymphocytes and FoxP3-Positive Regulatory T Cells Predict Distant Metastatic Relapse and Survival of Clear Cell Renal Cell CarcinomaSignaling defects in anti-tumor T cellsDiminished IFN-gamma and IL-10 and elevated Foxp3 mRNA expression in the cervix are associated with CIN 2 or 3.High-avidity autoreactive CD4+ T cells induce host CTL, overcome T(regs) and mediate tumor destruction.A novel T cell-based vaccine capable of stimulating long-term functional CTL memory against B16 melanoma via CD40L signaling.Mucosal adjuvants and long-term memory development with special focus on CTA1-DD and other ADP-ribosylating toxins.T cells in gastric cancer: friends or foesLocal expression of interleukin-2 by B16 melanoma cells results in decreased tumour growth and long-term tumour dormancy.Depletion of CD4+ CD25+ regulatory T cells inhibits local tumour growth in a mouse model of B cell lymphoma.Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients.Frequency of regulatory T cells in peripheral blood and in tumour-infiltrating lymphocytes correlates with poor prognosis in renal cell carcinoma.Potent anti-tumor responses to immunization with dendritic cells loaded with tumor tissue and an NKT cell ligand.
P2860
Q28383820-FDD5EDFF-B42A-43A8-822E-719268CF93F0Q33811204-C8666E95-AB22-4247-8955-C2E6BF07BD78Q34360520-A1466512-0174-4D3C-8049-8B6D6F528F76Q36689038-62756F3B-17E1-4C78-A9E7-13B2A2F0762AQ36809780-30CBF09E-95D4-4D3A-9C8E-662DB46F83CDQ36865032-1293902E-0F5E-4E9A-8D7C-B8C4162C7A53Q37063739-361CC800-CDDD-4D8C-9104-02C0DB778574Q37226721-44D383BF-712D-423E-8DA8-7987EB8FDA12Q37355703-918728CC-9368-4F0E-9BA7-158C40F13CE1Q37729596-04D131F8-611D-4D54-A84A-A9A6A591D570Q37789144-A5D3F796-82CF-404E-8491-2BE76C6BE84CQ38018319-8A9F64E3-85D2-4E93-9304-2DE8FA39EDB9Q39235364-15BBEBC8-A08E-4161-B797-755209AB8F1BQ40002381-62763B67-41C2-4C9B-A63A-F204C422ABFEQ42742001-3B67A995-F0B5-470E-AF31-7A77B6C9BC8DQ46264501-6D3E9E70-F853-4600-8924-8EA15C208102Q54278437-B2DA9988-D735-44B8-A157-A18AA91B7E98
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Immune regulation in tumor-bearing hosts.
@ast
Immune regulation in tumor-bearing hosts.
@en
type
label
Immune regulation in tumor-bearing hosts.
@ast
Immune regulation in tumor-bearing hosts.
@en
prefLabel
Immune regulation in tumor-bearing hosts.
@ast
Immune regulation in tumor-bearing hosts.
@en
P1476
Immune regulation in tumor-bearing hosts.
@en
P2093
Clare Baecher-Allan
David E Anderson
P304
P356
10.1016/J.COI.2006.01.010
P577
2006-02-07T00:00:00Z